Market News

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.

Gentrack Group (ASX:GTK) has delivered impressive revenue growth for the year ending 30 September 2024, with group revenue rising 25.5% from $169.9m in 2023 to $213.2m. This was driven by strong demand across its utilities and airport management software segments, bolstered by new customer wins and upgrades. However, cost pressures tempered the overall results. EBITDA remained

A broad stock rally propelled the Dow Jones, S&P 500, and small-cap focused Russell 2000 index to new record highs on Monday. Investors were optimistic that President-elect Donald Trump’s selection for Treasury Secretary, Scott Bessent, would steer the economy effectively without triggering inflation. The Dow rose 440.06 points, or 0.99 per cent, to 44,736.57. The

INOVIQ (ASX:IIQ) has received a $1.018m refund under the Australian Government’s Research & Development (R&D) Tax Incentive program for the fiscal year ending 30 June 2024. The refund reflects $2.7m spent on eligible R&D activities, excluding certain overseas expenditures. The Melbourne-based company specialises in developing diagnostics and therapeutics for cancer. Among its advancements is the

Altech Batteries (ASX:ATC) has signed a second Offtake Letter of Intent for its CERENERGY GridPack Battery Energy Storage System, marking a significant step in its commercialisation efforts. The agreement is with Referenzkraftwerk Lausitz GmbH (RefLau), a joint venture between German renewable energy firms Enertrag SE and Energiequelle GmbH. This follows Altech’s initial offtake agreement, announced

Respiri (ASX:RSH) has announced a binding agreement to acquire the business and assets of Orb Health Inc, a Texas-based provider of remote patient monitoring (RPM) and chronic care management (CCM) services. The acquisition, valued at US$9m, is a pivotal move for Respiri as it expands its footprint in the US healthcare market. Orb Health is

UniCredit (BIT:CRDI) has launched a surprise €10.5bn all-share bid for its domestic rival Banco BPM (BIT:BAMI), sparking political backlash and concerns about the impact on Italy’s broader banking strategy. The move could disrupt government plans to consolidate Banco BPM with the state-owned Monte dei Paschi di Siena (MPS), creating a third major player in Italy’s

Macy’s (NYSE: M) has delayed its fiscal third-quarter earnings release after discovering that an employee hid between $132m and $154m in delivery expenses over several years. The retailer announced on Monday that the employee responsible for small-package delivery expense accounting made “erroneous accounting accrual entries” from late 2021 through the quarter ending 2 November 2024.

The Russell 2000 index reached an all-time high on Monday, buoyed by expectations of tax cuts under a second Donald Trump administration and optimism over further Federal Reserve rate cuts. The index represents the performance of about 2,000 small-cap companies in the US. It’s a subset of the Russell 3000 Index, which includes the 3,000

Archer Materials (ASX:AXE) is leveraging innovative carbon-based materials to solve high-value problems in quantum technology and bio-sensing. The company is exploring the use of carbon nanomaterials, like “nano onions”, for quantum applications due to their long spin coherence times. The company is also developing a graphene-based bio-chip aimed at addressing chronic kidney disease, which affects